GARDASIL - Medsafe
WPC-V501-I-022011 2 . Invasive cervical cancer cannot be used as an endpoint for efficacy studies of HPV vaccines because of the importance of employing secondary prevention measures.
Download GARDASIL - Medsafe
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
GARDASIL9 - Merck & Co.
www.merck.com1 Patient Information about GARDASIL®9 (pronounced “gard-Ah-sill nīn”) (Human Papillomavirus 9-valent Vaccine,Recombinant) Read this information with care before getting GARDASIL®9.
HIGHLIGHTS OF PRESCRIBING INFORMATION Each dose of ...
www.merck.com4 5.2 Managing Allergic Reactions Appropriate medical treatment and supervision must be readily available in case of anaphylactic reactions following the administration of GARDASIL9.
HPV (Human Papillomavirus) Vaccine: What You Need to …
immunize.orgProblems that could happen after any injected vaccine: •People sometimes faint after a medical procedure, including vaccination. Sitting or lying down for about
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
www.ema.europa.eu3 Alternatively, Gardasil can be administered according to a 3-dose (0.5ml at 0, 2, 6months) schedule. The second dose should be administered at least one month after the first dose and the third dose
Product, Summary, Characteristics, Summary of product characteristics, Gardasil
HPV Vaccine – 2 or 3 Doses?
eziz.orgIMM-1254 (10/17) 9˜14 YEARS 1 2 DOSES 3 DOSES For Health Professionals 15+ YEARS 4 OR COMPROMISED IMMUNE SYSTEM3 For more information, see: www.cdc.gov/vaccines/hcp ...
Prospecto: Información para el usuario Gardasil ...
www.msd.esProspecto: Información para el usuario. Gardasil 9suspensión inyectable en jeringa precargada . Vacuna nonavalente frente al Virus del Papiloma Humano (Recombinante, adsorbida)
MERCK VACCINE PATIENT ASSISTANCE PROGRAM …
www.merckhelps.comSECTION 1: Applicant Information (Patient should complete all information in Section 1.) Patient’s First Name US Resident* Yes No Last Name Address Apt. No. City State ZIP Phone Date of …
Gardasil 9 supply, influenza, zoster vaccine, NIR and PMS ...
www.influenza.org.nzNIR and PMS changes The NIR, practice management systems (PMS) and Ministry payment systems are being updated to include the funded zoster vaccine.
Bijsluiter: informatie voor de gebruiker Gardasil 9 ...
www.laatjevaccineren.be1 Bijsluiter: informatie voor de gebruiker Gardasil 9, suspensie voor injectie in een voorgevulde spuit 9-valent humaan-papillomavirusvaccin (recombinant, geadsorbeerd)